Q. Tan

Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women

Fenghua Wang, Yu-hong Li, Huiyan Luo, 2021, JAMA network open.

Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study

Fenghua Wang, Yu-hong Li, Deshen Wang, 2020, Investigational New Drugs.

Paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced borderline-resectable esophageal squamous cell carcinoma: a phase II clinical trial

Qiaoqiao Li, Yihuai Hu, Hong Yang, 2021, Esophagus.

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

P. Ding, Z. Pan, M. Qiu, 2024, PLoS medicine.